GB0526132D0 - Combination Therapy - Google Patents

Combination Therapy

Info

Publication number: GB0526132D0
Authority: GB; United Kingdom
Prior art keywords: combination therapy; therapy; combination
Prior art date: 2005-12-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GB0526132A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

AstraZeneca AB

Original Assignee

AstraZeneca AB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-22

Filing date

2005-12-22

Publication date

2006-02-01

2005-12-22 Application filed by AstraZeneca AB filed Critical AstraZeneca AB

2005-12-22 Priority to GB0526132A priority Critical patent/GB0526132D0/en

2006-02-01 Publication of GB0526132D0 publication Critical patent/GB0526132D0/en

2006-12-19 Priority to BRPI0620118-0A priority patent/BRPI0620118A2/en

2006-12-19 Priority to CNA2006800488767A priority patent/CN101346142A/en

2006-12-19 Priority to SI200631009T priority patent/SI1965801T1/en

2006-12-19 Priority to ES06820574T priority patent/ES2361682T3/en

2006-12-19 Priority to US12/158,266 priority patent/US20080306094A1/en

2006-12-19 Priority to NZ568812A priority patent/NZ568812A/en

2006-12-19 Priority to DK06820574.9T priority patent/DK1965801T3/en

2006-12-19 Priority to CA002631676A priority patent/CA2631676A1/en

2006-12-19 Priority to PL06820574T priority patent/PL1965801T3/en

2006-12-19 Priority to DE602006020919T priority patent/DE602006020919D1/en

2006-12-19 Priority to JP2008546594A priority patent/JP2009520787A/en

2006-12-19 Priority to AU2006328201A priority patent/AU2006328201B2/en

2006-12-19 Priority to KR1020087016943A priority patent/KR20080077678A/en

2006-12-19 Priority to PCT/GB2006/004768 priority patent/WO2007071970A2/en

2006-12-19 Priority to AT06820574T priority patent/ATE502641T1/en

2006-12-19 Priority to EP06820574A priority patent/EP1965801B1/en

2006-12-19 Priority to PT06820574T priority patent/PT1965801E/en

2008-05-28 Priority to IL191797A priority patent/IL191797A0/en

2008-06-02 Priority to NO20082566A priority patent/NO20082566L/en

2008-06-17 Priority to ZA200805245A priority patent/ZA200805245B/en

2009-01-19 Priority to HK09100508.6A priority patent/HK1123976A1/en

2011-05-18 Priority to HR20110365T priority patent/HRP20110365T1/en

2011-05-20 Priority to CY20111100490T priority patent/CY1111482T1/en

Status Ceased legal-status Critical Current

Links

GB0526132A 2005-12-22 2005-12-22 Combination Therapy Ceased GB0526132D0 (en)

Priority Applications (24)

Application Number	Priority Date	Filing Date	Title
GB0526132A GB0526132D0 (en)	2005-12-22	2005-12-22	Combination Therapy
PT06820574T PT1965801E (en)	2005-12-22	2006-12-19	Combination of azd2171 and pemetrexed
DE602006020919T DE602006020919D1 (en)	2005-12-22	2006-12-19	COMBINATION OF AZD2171 AND PEMETREXED
AU2006328201A AU2006328201B2 (en)	2005-12-22	2006-12-19	Combination of AZD2171 and pemetrexed
SI200631009T SI1965801T1 (en)	2005-12-22	2006-12-19	Combination of azd2171 and pemetrexed
ES06820574T ES2361682T3 (en)	2005-12-22	2006-12-19	COMBINATION OF AZD2171 AND PEMETREXED.
US12/158,266 US20080306094A1 (en)	2005-12-22	2006-12-19	Combination of Azd2171 and Pemetrexed
NZ568812A NZ568812A (en)	2005-12-22	2006-12-19	Combination of AZD2171 and pemetrexed
DK06820574.9T DK1965801T3 (en)	2005-12-22	2006-12-19	Combination of azd2171 and pemetrexed
CA002631676A CA2631676A1 (en)	2005-12-22	2006-12-19	Combination of azd2171 and pemetrexed
PL06820574T PL1965801T3 (en)	2005-12-22	2006-12-19	Combination of azd2171 and pemetrexed
BRPI0620118-0A BRPI0620118A2 (en)	2005-12-22	2006-12-19	use of azd2171 or a pharmaceutically acceptable salt thereof and permetrexed, pharmaceutical composition, kit, and method for producing an antiangiogenic, and / or vascular permeability reducing effect in a warm-blooded animal
JP2008546594A JP2009520787A (en)	2005-12-22	2006-12-19	Combination of AZD2171 and pemetrexed
CNA2006800488767A CN101346142A (en)	2005-12-22	2006-12-19	Combination of AZD2171 and pemetrexed
KR1020087016943A KR20080077678A (en)	2005-12-22	2006-12-19	Combination of ABD2171 and pemetrexed
PCT/GB2006/004768 WO2007071970A2 (en)	2005-12-22	2006-12-19	Combination of azd2171 and pemetrexed
AT06820574T ATE502641T1 (en)	2005-12-22	2006-12-19	COMBINATION OF AZD2171 AND PEMETREXED
EP06820574A EP1965801B1 (en)	2005-12-22	2006-12-19	Combination of azd2171 and pemetrexed
IL191797A IL191797A0 (en)	2005-12-22	2008-05-28	Combination of azd2171 and pemetrexed
NO20082566A NO20082566L (en)	2005-12-22	2008-06-02	Combination of AZ2171 and permetrexed
ZA200805245A ZA200805245B (en)	2005-12-22	2008-06-17	Combination of AXD2171 and pemetrexed
HK09100508.6A HK1123976A1 (en)	2005-12-22	2009-01-19	Combination of azd2171 and pemetrexed azd2171
HR20110365T HRP20110365T1 (en)	2005-12-22	2011-05-18	Combination of azd2171 and pemetrexed
CY20111100490T CY1111482T1 (en)	2005-12-22	2011-05-20	COMBINATION AZD2171 AND PERMETRAXED

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB0526132A GB0526132D0 (en)	2005-12-22	2005-12-22	Combination Therapy

Publications (1)

Publication Number	Publication Date
GB0526132D0 true GB0526132D0 (en)	2006-02-01

Family

ID=35840977

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB0526132A Ceased GB0526132D0 (en)	2005-12-22	2005-12-22	Combination Therapy

Country Status (4)

Country	Link
CN (1)	CN101346142A (en)
ES (1)	ES2361682T3 (en)
GB (1)	GB0526132D0 (en)
ZA (1)	ZA200805245B (en)

2005
- 2005-12-22 GB GB0526132A patent/GB0526132D0/en not_active Ceased
2006
- 2006-12-19 CN CNA2006800488767A patent/CN101346142A/en active Pending
- 2006-12-19 ES ES06820574T patent/ES2361682T3/en active Active
2008
- 2008-06-17 ZA ZA200805245A patent/ZA200805245B/en unknown

Also Published As

Publication number	Publication date
CN101346142A (en)	2009-01-14
ZA200805245B (en)	2009-11-25
ES2361682T3 (en)	2011-06-21

Publication	Publication Date	Title
HK1205935A1 (en)	2015-12-31	Non-lithotripsic kidney-stone therapy
GB0506147D0 (en)	2005-05-04	Therapeutic agents
GB0417481D0 (en)	2004-09-08	Combination therapy
GB0428180D0 (en)	2005-01-26	Combination therapy
GB0505725D0 (en)	2005-04-27	Therapeutic agents
GB0505437D0 (en)	2005-04-20	Therapeutic agents
ZA200709627B (en)	2009-08-26	Combination therapy
GB0518819D0 (en)	2005-10-26	Therapeutic agents
GB0504206D0 (en)	2005-04-06	Combination therapy
GB0518817D0 (en)	2005-10-26	Therapeutic agents
GB0424339D0 (en)	2004-12-08	Combination therapy
GB0509052D0 (en)	2005-06-08	Combination therapy
GB0516661D0 (en)	2005-09-21	Therapeutic agents
GB0514738D0 (en)	2005-08-24	Therapeutic agents
GB0507003D0 (en)	2005-05-11	Therapeutic
GB0518720D0 (en)	2005-10-19	Therapeutic combination
GB0501655D0 (en)	2005-03-02	Therapeutic use
GB0421436D0 (en)	2004-10-27	Combination therapy
GB0421438D0 (en)	2004-10-27	Combination therapy
GB0500658D0 (en)	2005-02-23	Combination therapy
GB0506725D0 (en)	2005-05-11	Combination therapy
GB0513778D0 (en)	2005-08-10	Combination therapy
GB0502949D0 (en)	2005-03-16	Combination therapy
GB0506726D0 (en)	2005-05-11	Combination therapy
GB0514347D0 (en)	2005-08-17	Combination therapy

Legal Events

Date	Code	Title	Description
2007-06-27	AT	Applications terminated before publication under section 16(1)